Laser Sintered Magnesium-Calcium Silicate/Poly-ε-Caprolactone Scaffold for Bone Tissue Engineering.

Current scaffolds for bone tissue engineering often lack sufficient bioactivity and degradation rates to match natural bone regeneration. While poly-ε-caprolactone (PCL) is widely used for its mechanical properties, it is hydrophobic and degrades slowly, limiting its osteogenic potential. Researchers have explored adding bioactive ceramics like magnesium-calcium silicate (Mg-CS) to improve these properties. Prior studies have shown that Mg-CS can enhance hydrophilicity and promote apatite formation, but the integration of Mg-CS into PCL scaffolds using laser sintering remains underexplored. This gap motivated the investigation of Mg-CS/PCL composites for their potential in bone regeneration. No prior work had resolved the effects of varying Mg-CS content on cell behavior and scaffold performance. The field needs a clearer understanding of how ceramic additives influence both material properties and cellular responses in 3D-printed scaffolds.

The aim of this study was to develop and evaluate 3D-printed magnesium-calcium silicate/poly-ε-caprolactone (Mg-CS/PCL) scaffolds for bone tissue engineering. The researchers focused on assessing how Mg-CS content affects scaffold properties such as porosity, hydrophilicity, and degradation rate. They also sought to determine the impact of Mg-CS on the formation of a bone-like apatite layer in simulated body fluid. In addition, the study aimed to evaluate the biocompatibility of these scaffolds with human mesenchymal stem cells (hMSCs) and to measure cell adhesion, proliferation, and osteogenic differentiation. The motivation was to create a scaffold that supports both structural integrity and biological activity. The researchers proposed that the addition of Mg-CS could improve scaffold performance compared to pure PCL. This work addresses the need for biomaterials that combine mechanical stability with enhanced osteoinductive properties.

The researchers used laser sintering technology to fabricate 3D scaffolds from a composite of magnesium-calcium silicate (Mg-CS) and poly-ε-caprolactone (PCL). They varied the Mg-CS content in the composite, testing different percentages to determine optimal scaffold properties. The scaffolds were analyzed for porosity, macropore structure, and hydrophilicity using standard material characterization techniques. The degradation rate was assessed by measuring mass loss over time in simulated body fluid. The formation of a bone-like apatite layer was observed after soaking the scaffolds in simulated body fluid for one day. Human mesenchymal stem cells (hMSCs) were seeded onto the scaffolds to evaluate biocompatibility, cell adhesion, and proliferation. The expression of focal adhesion kinase and osteogenesis-related proteins was measured to assess cell behavior. The study combined material science methods with in vitro cell culture techniques to evaluate scaffold performance.

The Mg-CS/PCL scaffolds exhibited high porosity and interconnected macropores, which are essential for cell infiltration and nutrient transport. Compared to pure PCL scaffolds, the addition of Mg-CS significantly improved hydrophilicity and increased the degradation rate. Scaffolds with more than 20% Mg-CS content formed a dense bone-like apatite layer after just one day in simulated body fluid. In vitro tests showed that hMSCs adhered and proliferated well on all scaffolds, indicating biocompatibility. Higher Mg-CS content led to increased focal adhesion kinase expression and enhanced cell adhesion behavior. When Mg-CS content exceeded 10%, the scaffolds released Si ions that stimulated hMSC proliferation and the production of osteogenesis-related proteins. The presence of Mg-CS significantly enhanced osteogenic differentiation compared to pure PCL scaffolds. These results suggest that Mg-CS/PCL composites have strong potential as bioactive scaffolds for bone tissue engineering.

The study demonstrated that Mg-CS/PCL scaffolds fabricated via laser sintering possess high porosity and interconnected structures suitable for bone tissue engineering. The addition of Mg-CS improved scaffold hydrophilicity, degradation rate, and apatite formation in simulated body fluid. Human mesenchymal stem cells adhered and proliferated well on these scaffolds, with higher Mg-CS content promoting cell adhesion and osteogenic differentiation. The release of Si ions from Mg-CS enhanced osteogenesis-related protein expression in hMSCs. These findings suggest that Mg-CS/PCL composites may serve as promising biomaterials for bone regeneration. The results align with the authors' claim that these scaffolds have potential for next-generation tissue engineering applications. The study supports the idea that Mg-CS can be effectively integrated into PCL scaffolds to improve their bioactivity and osteoinductive properties. The authors propose that these findings may guide future scaffold design for bone tissue engineering.